Soros Fund Management Llc decreased its stake in Mondelez Intl Inc (MDLZ) by 7.67% based on its latest 2019Q1 regulatory filing with the SEC. Soros Fund Management Llc sold 100,000 shares as the company’s stock rose 8.86% with the market. The hedge fund held 1.20 million shares of the consumer non-durables company at the end of 2019Q1, valued at $60.09 million, down from 1.30M at the end of the previous reported quarter. Soros Fund Management Llc who had been investing in Mondelez Intl Inc for a number of months, seems to be less bullish one the $78.58 billion market cap company. The stock increased 1.04% or $0.56 during the last trading session, reaching $54.55. About 5.08M shares traded. Mondelez International, Inc. (NASDAQ:MDLZ) has risen 32.15% since June 13, 2018 and is uptrending. It has outperformed by 27.72% the S&P500. Some Historical MDLZ News: 02/04/2018 – Mondelez International Inc. CDS Tightens 8 Bps, Most in 19 Mos; 01/05/2018 – MONDELEZ CALL ENDS; 28/03/2018 – Mondelēz International Foundation Launches Healthy Lifestyle Programs Covering 10 Countries; 06/05/2018 – Tate’s Deal Could Be Announced Monday; 16/05/2018 – Activists Buy Newell, Citi; Sell AIG, Mondelez: 13F Roundup; 01/05/2018 – MONDELEZ 1Q ADJ EPS 62C, EST. 61C; 05/04/2018 – Mondelez International CDS Tightens 8 Bps, Most in 19 Months; 14/05/2018 – Public-Private Partnerships Are Key To Addressing Childhood Obesity; 03/05/2018 – S&PGR Rts Mondelez International’s Sr Unscrd Nts ‘BBB’; 01/05/2018 – Mondelez bags sales, profit beat
Sivik Global Healthcare Llc increased its stake in Eli Lilly & Co (LLY) by 27.27% based on its latest 2019Q1 regulatory filing with the SEC. Sivik Global Healthcare Llc bought 15,000 shares as the company’s stock declined 3.37% while stock markets rallied. The hedge fund held 70,000 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $9.08M, up from 55,000 at the end of the previous reported quarter. Sivik Global Healthcare Llc who had been investing in Eli Lilly & Co for a number of months, seems to be bullish on the $106.12 billion market cap company. The stock increased 2.70% or $3.03 during the last trading session, reaching $115.24. About 3.71M shares traded. Eli Lilly and Company (NYSE:LLY) has risen 39.18% since June 13, 2018 and is uptrending. It has outperformed by 34.75% the S&P500. Some Historical LLY News: 12/04/2018 – JNJ: INVOKANA IMPROVED RENAL OUTCOMES IN TYPE 2 DIABETES; 10/05/2018 – STAT Plus: Eli Lilly acquires small biotech for $1.6 billion to strengthen cancer immunotherapy pipeline; 10/04/2018 – BerGenBio Completes Recruitment Into First Stage of Phase Il NSCLC Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA®; 09/03/2018 – Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology; 30/04/2018 – Merck Seeks Approval for Keytruda Combo as First-Line Treatment for Metastatic Nonsquamous NSCLC; 04/04/2018 – Eli Lilly to Receive Exclusive Worldwide License to Sigilon’s Afibromer Technology for Islet Cell Encapsulation; 10/05/2018 – Eli Lilly: Deal Bolsters Immuno-Oncology Program; 24/04/2018 – Eli Lilly Raises 2018 View To EPS $4.52-EPS $4.62; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN PHASE 3 KEYNOTE-042 STUDY, SIGNIFICANTLY IMPROVING OS AS FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC NSCLC PATIENTS EXPRESSING PD; 12/04/2018 – INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Soros Fund Management Llc, which manages about $4.31B US Long portfolio, upped its stake in Silicon Laboratories Inc (Prn) by 3.50 million shares to 17.90M shares, valued at $19.50 million in 2019Q1, according to the filing. It also increased its holding in Salesforce Com Inc (NYSE:CRM) by 110,000 shares in the quarter, for a total of 315,000 shares, and has risen its stake in Arris International Plc.
Investors sentiment decreased to 0.99 in 2019 Q1. Its down 0.08, from 1.07 in 2018Q4. It dropped, as 54 investors sold MDLZ shares while 399 reduced holdings. 127 funds opened positions while 321 raised stakes. 1.04 billion shares or 0.32% less from 1.04 billion shares in 2018Q4 were reported. Ohio-based Keybank Association Oh has invested 0.28% in Mondelez International, Inc. (NASDAQ:MDLZ). Beck Mack & Oliver Limited Com has 6,205 shares for 0.01% of their portfolio. Ironwood Fincl Ltd Liability Com stated it has 100 shares. Moreover, Jennison Associate Lc has 0.26% invested in Mondelez International, Inc. (NASDAQ:MDLZ). Auxier Asset Management holds 0.4% or 39,410 shares. Us Commercial Bank De owns 884,342 shares. Evermay Wealth Mgmt Ltd Limited Liability Company holds 0.11% of its portfolio in Mondelez International, Inc. (NASDAQ:MDLZ) for 7,702 shares. Shine Inv Advisory has invested 0.05% in Mondelez International, Inc. (NASDAQ:MDLZ). Cim Mangement Incorporated accumulated 12,990 shares or 0.25% of the stock. Aldebaran Fincl, a Tennessee-based fund reported 4,707 shares. British Columbia Investment Mgmt has invested 0.17% in Mondelez International, Inc. (NASDAQ:MDLZ). Inv Management Of Virginia Llc accumulated 9,319 shares. Company Of Toledo Na Oh invested in 0.1% or 7,845 shares. Whitnell & stated it has 48,880 shares or 0.94% of all its holdings. Ameriprise has invested 0.39% of its portfolio in Mondelez International, Inc. (NASDAQ:MDLZ).
Since February 1, 2019, it had 0 insider purchases, and 2 selling transactions for $1.90 million activity. Pleuhs Gerhard W. also sold $1.40 million worth of Mondelez International, Inc. (NASDAQ:MDLZ) on Wednesday, February 13.
More notable recent Mondelez International, Inc. (NASDAQ:MDLZ) news were published by: Nasdaq.com which released: “Mondelez (MDLZ) to Boost Snacks Unit, Invests in Hu Master – Nasdaq” on April 22, 2019, also Nasdaq.com with their article: “Mondelez (MDLZ) Q4 Earnings In Line, Revenues Top Estimates – Nasdaq” published on January 31, 2019, Finance.Yahoo.com published: “Here is What Hedge Funds Think About Mondelez International Inc (MDLZ) – Yahoo Finance” on June 06, 2019. More interesting news about Mondelez International, Inc. (NASDAQ:MDLZ) were released by: Bizjournals.com and their article: “Do CEOs really make 100 times more than employees? They do at these companies – Puget Sound Business Journal (Seattle)” published on May 22, 2019 as well as Nasdaq.com‘s news article titled: “Why Is Mondelez (MDLZ) Up 5.8% Since Last Earnings Report? – Nasdaq” with publication date: November 28, 2018.
Analysts await Mondelez International, Inc. (NASDAQ:MDLZ) to report earnings on July, 24. They expect $0.57 EPS, up 1.79% or $0.01 from last year’s $0.56 per share. MDLZ’s profit will be $821.05 million for 23.93 P/E if the $0.57 EPS becomes a reality. After $0.65 actual EPS reported by Mondelez International, Inc. for the previous quarter, Wall Street now forecasts -12.31% negative EPS growth.
Since January 15, 2019, it had 1 buy, and 9 insider sales for $151.46 million activity. On Wednesday, June 5 the insider Smiley Joshua L bought $50,281. The insider Zulueta Alfonso G sold $480,000.
Sivik Global Healthcare Llc, which manages about $250.21M and $271.40M US Long portfolio, decreased its stake in Qiagen N.V. Com Stk by 30,800 shares to 80,000 shares, valued at $3.25 million in 2019Q1, according to the filing. It also reduced its holding in Abbott Laboratories (NYSE:ABT) by 15,000 shares in the quarter, leaving it with 100,000 shares, and cut its stake in Intuitive Surgical Inc (NASDAQ:ISRG).
More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: Finance.Yahoo.com which released: “Here’s Why Array BioPharma Is Surging Today – Yahoo Finance” on May 21, 2019, also Finance.Yahoo.com with their article: “Hereâ€™s What Hedge Funds Think About Philip Morris International Inc. (PM) – Yahoo Finance” published on June 11, 2019, Prnewswire.com published: “Lilly to Showcase Scientific Innovation within Dermatology Portfolio at 24th World Congress of Dermatology – PRNewswire” on June 05, 2019. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: Benzinga.com and their article: “Elanco Animal Health Begins Trading After Eli Lilly Split – Benzinga” published on March 11, 2019 as well as Seekingalpha.com‘s news article titled: “Here’s Why Eli Lilly Is Cutting The Price Of Humalog – Seeking Alpha” with publication date: May 29, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.